A 24-week multi-center, double-blind, placebo controlled dose-range finding study to investigate the efficacy and safety of oral QBW251 in COPD patients on triple inhaled therapy (LABA/LAMA/ICS)

Project: Research

Project Details

StatusActive
Effective start/end date29/10/1928/10/24

Keywords

  • clinical trial
  • treatment efficacy
  • treatment safety
  • Chronic obstructive pulmonary disease
  • COPD